CING Joins European Initiative to Enhance Cardiovascular Diagnostics Using AI
The Cyprus Institute of Neurology and Genetics (CING) has joined the European research project PoCCardio, aimed at revolutionising the prediction and prevention of myocardial infarctions through advanced technology.
About PoCCardio: A Groundbreaking European Collaboration
PoCCardio, which stands for ‘Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients’, brings together prestigious institutions from across Europe. The initiative seeks to develop sophisticated diagnostic tools tailored for individuals at heightened risk of cardiovascular diseases. The project boasts a total funding of €14 million from the European Union, under the Horizon Europe programme, and CING has secured €540,000 to support its valuable contributions.
Participating in PoCCardio are 1,800 patients with a history of heart attacks, whose medical data and biomarker measurements will be meticulously collected. This wealth of information will aid in enhancing diagnostic precision and improving prognosis for heart conditions.
AI at the Forefront of Predictive Healthcare
Central to CING’s role in PoCCardio is its Department of Bioinformatics, which specializes in computational diagnostics. The department, led by Associate Scientist Dr Anastasios Oulas, will utilise artificial intelligence to better predict the likelihood of myocardial infarctions, ensuring that patients receive timely, personalized treatments.
“Through modern bioinformatics, we aim to accurately assess the risk of heart attacks, allowing healthcare professionals to provide targeted interventions,” Dr Oulas commented. Collaborating with leading European research centres enhances CING’s capabilities, ultimately contributing to improved healthcare outcomes.
The PoCCardio initiative leverages advanced algorithms and network generation tools. These will help identify significant interactions among various biomarkers, gathering data from genomic and proteomic sources collected during the project. The ability to create comprehensive networks will enable medical professionals to train algorithms that efficiently predict heart attack risk.
Local Context: Digital Policy and Cybersecurity Frameworks
The introduction of innovative technologies in healthcare, such as those in the PoCCardio project, aligns with Cyprus’s broader digital policy objectives. Recent legislation, including the NIS 2 Directive aimed at enhancing cybersecurity across member states, resonates with the project’s commitment to safeguarding sensitive health data.
Existing digital policy players in Cyprus, such as the Department of e-Government and the Data Protection Authority, play vital roles in ensuring that organisations like CING adhere to high standards of data protection and cybersecurity. As healthcare increasingly relies on data-driven technologies, integrating robust cybersecurity measures becomes critical to protect patient information.
Additionally, the Digital Services Act (DSA) further emphasises the importance of accountability and responsibility for digital services, ensuring that user data is handled with utmost care. CING’s considerations for cybersecurity will consequently shape the development and deployment of its innovative diagnostic tools in alignment with these legislative frameworks.
Dr Oulas also highlighted the importance of nurturing local talent within the cybersecurity and AI sectors, indicating that the skills gap remains a pressing concern. “The need for skilled professionals in AI and cybersecurity is growing, especially as we integrate these technologies into healthcare. Investing in education and training is essential to meet this demand,” he stated.
The Future of AI in Cardiovascular Health
CING’s participation not only enhances its reputation within cutting-edge European research but also aligns with the Horizon Europe’s mission to improve innovation capacity and research excellence across Europe. Building advanced AI-driven diagnostic protocols for heart attack risk prediction positions Cyprus at the forefront of medical innovation.
Through its involvement in PoCCardio, CING demonstrates a commitment to not only advancing healthcare solutions but also reinforcing the importance of cybersecurity and regulatory compliance in the digital age. The institute’s efforts to develop predictive tools underline the potential of AI in enhancing precision medicine and facilitating more effective treatment options for patients.
Moving forward, initiatives like PoCCardio exemplify how collaboration with European institutions can yield significant dividends in public health. As CING fosters partnerships and raises the standards of healthcare delivery in Cyprus, it stands as a model for how technology can be harnessed responsibly to improve patient outcomes and protect sensitive information in an ever-evolving digital landscape.
